11 articles with Hemovent
Hemovent GmbH announced that it has received CE Marking for its MOBYBOX™ ECLS System, allowing the company to market its innovative product throughout the European Union.
Hemovent Reports Successful in vivo Pilot Study of MOBYBOX™ by Minnesota Resuscitation Consortium (MRC), Which is Developing a ‘Super Ambulance’ Equipped to Advance Cardiac Arrest Treatment
“I’m not sure I’m even going to call them ‘ambulances’,” says MRC Director, Dr. Demetri Yannopoulos. “They’re more like an emergency department substation that’s mobile. I believe the MOBYBOX system’s small size and mobility make it the ideal ECMO device for super ambulances.”
The MOBYBOX™ System is a self-contained and fully integrated ExtraCorporeal Membrane Oxygenation / ExtraCorporeal Life Support system designed with an ultimate focus on safety, ease of use, mobility, and performance in order to support or replace heart and lung function in the event of cardiac and/or respiratory failure.
Hemovent Receives ISO 13485 Quality Management Systems Certification as Penultimate Step in CE Mark Approval Process for Its MOBYBOX™ ECMO/ECLS System
MOBYBOX is a self-contained and fully integrated system designed with an ultimate focus on safety, ease of use, mobility, and performance in order to support or replace heart and lung function in the event of cardiac and/or respiratory failure.
Hemovent Reports “Stunning Results” from Completion of GLP Standardized in vivo Trial for Long-Term Use of Its Next-Gen ExtraCorporeal Membrane Oxygenation (ECMO) System Mobybox™
Key endpoints in all-six subjects — no hemolysis, no thrombosis at low anticoagulation and no functional device wear — will be used for CE mark registration and FDA submission of Mobybox™, the initial application of Hemovent’s Bionique™ platform.
Hemovent announced today it has established a Scientific Advisory Board with the appointment of Professor Alain Combes, MD, PhD.
Hemovent Successfully Debuts ExtraCorporeal Life Support (ECLS) Device from its Artificial Lung Platform
Hemovent GmbH announced today that its ECLS device got overwhelmingly enthusiastic clinician feedback at REANIMATE 4, one of the leading-edge endovascular resuscitation conferences, organized by the ED ECMO Project.
Hemovent Expands Series A Financing To Fast-Forward Development Of Its Artificial Lung Platform, Including Applications For Extracorporeal Life Support (ECLS) And Extracorporeal Co2 Removal (ECCO2R)
Hemovent Successfully Completes First Series Of In Vivo Trials Of Its Next-Gen Extracorporeal Life Support (ECLS) System
Hemovent Receives Government Grant To Fast-Forward Development Of Its Next-Gen Artificial Lung Technologies
Hemovent Files Two Additional Patent Applications For Its Portable ECMO Device For Both Circulatory And Respiratory Support